Skip to main content

Day: July 5, 2023

Initial Data from Allarity’s Phase 2 Trial of IXEMPRA® Indicate Potential for Improved Clinical Benefit in DRP®-Selected Metastatic Breast Cancer Patients

Boston, MA (July 5, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (Nasdaq: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, today announced initial results from its European Phase 2 clinical trial evaluating the efficacy of IXEMPRA® in metastatic breast cancer (mBC) patients selected with the DRP®-IXEMPRA® companion diagnostic (CDx) candidate. Researchers prescreened mBC patients using Allarity’s DRP®-IXEMPRA® CDx, a complex transcriptomic signature comprising multiple mRNA biomarkers of drug response/resistance. Patients were assigned a DRP®-score, and those with scores above 67% were selected for treatment with IXEMPRA®. Of the 36 patients screened with the DRP®-IXEMPRA® CDx, investigators identified...

Continue reading

Magna Announces Date for Q2 2023 Results Call

AURORA, Ontario, July 05, 2023 (GLOBE NEWSWIRE) — Magna International Inc. (TSX:MG) (NYSE:MGA) MAGNA ANNOUNCES DATE FOR Q2 2023 RESULTS CALLFRIDAY – AUGUST 4, 20238:00 AM ET DIAL IN NUMBERSToll-Free: 1-800-899-2086International: 1-416-641-6701Webcast: www.magna.com Slide presentation will be available on our website prior to the call REBROADCAST INFORMATIONReplay available 2 hours after the call until August 11, 2023Toll-Free: 1-800-558-5253International: 1-416-626-4100Reservation No.: 22027512INVESTOR CONTACTLouis Tonelli, Vice-President, Investor Relations louis.tonelli@magna.com 905-726-7035 TELECONFERENCE CONTACTNancy Hansford, Executive Assistant, Investor Relations nancy.hansford@magna.com 905-726-7108

Continue reading

Tarkett- Information on the total number of voting rights and shares in Tarkett’s share capital as of June, 30 2023

PARIS, FRANCE, July 5, 2023 – Information on the total number of voting rights and shares in Tarkett’s share capital as of June, 30 2023 (Article L233-8-II of the French Commercial Code andArticle 223-16 of the General Regulation of the Autorité des marchés financiers)Date Total number of shares in the share capital Total number of voting rightsAs of June 30, 2023   65,550,281   Number of theoretical voting rights: 102 273 570Number of exercisable voting rights: 102 164 260** After deduction of the treasury shares without voting rights. *** Investor Relations Contact investors@tarkett.com Media contacts Tarkett – communication@tarkett.com Brunswick – tarkett@brunswickgroup.com – Tel.: +33 (0) 1 53 96 83 83 About Tarkett With a history of 140 years, Tarkett is a worldwide leader in innovative and sustainable...

Continue reading

Lucy Scientific Discovery, Inc. Achieves Major Milestone with Successful Completion of its Acquisition of the Assets of Wesana Health

Company Forms Lucy Discoveries Holdings for Future Research and Development VANCOUVER, British Columbia, July 05, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. (“Lucy” or “the Company”) (NASDAQ: LSDI) proudly announces the successful completion of its acquisition of Wesana Health Inc.’s (“Wesana”) SANA-013 assets, marking a significant milestone in the field of mental health therapeutics. This acquisition strengthens Lucy’s position as a leader in innovative drug development research and accelerates the development and commercialization of this groundbreaking treatment. SANA-013 is being developed for the treatment of several mental health and central nervous system (CNS) related conditions, including Major Depressive Disorder (MDD), Migraine, Episodic Cluster Headaches,...

Continue reading

Non-Plastic Bag of Healthy Alternatives: Non-PVC IV Bags Market Set to Soar Past USD 3.97 Billion by 2030

The global Non-PVC IV Bags market size is expected to reach USD 3.97 billion by 2030 and exhibit a CAGR of 10.9% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing concerns about the use of PVC in healthcare settings, growing awareness of the potential risks and environmental impact of PVC, stringent regulations and guidelines promoting the use of alternative materials, rising demand for safer and more sustainable medical packaging solutions, is fueling the market’s growth. Westford, USA, July 05, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Non-PVC IV Bags Market, increasing adoption of non-PVC IV bags by hospitals and healthcare facilities, growing demand for eco-friendly and sustainable healthcare packaging solutions, development...

Continue reading

AAR to announce fourth quarter fiscal year 2023 results on July 18, 2023

Wood Dale, Illinois, July 05, 2023 (GLOBE NEWSWIRE) — AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, today announced that it will release financial results for its fourth quarter of fiscal year 2023, ended May 31, 2023, after the close of the New York Stock Exchange trading session on Tuesday, July 18, 2023. On Tuesday, July 18, 2023, at 3:45 p.m. Central time, AAR will hold a conference call to discuss the results. The conference call can be accessed by registering at https://register.vevent.com/register/BI6e42da77ed2046a0b652f6417faa6d56. Once registered, participants will receive a dial-in number and a unique PIN that will allow them to access the call. A replay of the conference call will be available for on-demand listening shortly after the completion...

Continue reading

Volcon Demonstrates Electric Vehicles to Key DoD Staff, Enters Funded Operational Energy Program

NASDAQ: VLCN – Volcon Demonstrates Electric Vehicles to Key DoD Staff NASDAQ: VLCN – Volcon Demonstrates Electric Vehicles to Key DoD Staff. Pictured is the Volcon Stag being charged by DD DANNAR’s electric, mobile power station in Camp Pendleton, CA.AUSTIN, Texas, July 05, 2023 (GLOBE NEWSWIRE) — Volcon, Inc. (NASDAQ: VLCN) announced today that it provided key Department of Defense staff a demonstration of the all-electric Stag UTV and EVO motorcycles under the funded program Electric Tactical Humanitarian Operations Response, or eTHOR, hosted by the NavalX SoCal Tech Bridge at Marine Corps Tactical Systems Support Activity (MCTSSA), in Camp Pendleton, CA. This project was developed through the SoCal Tech Bridge’s ongoing relationship with Naval Information Warfare Center – Pacific (NIWC-PAC)...

Continue reading

TRESU Investment Holding A/S – adjustment to full year 2023 guidance

TRESU INVESTMENT HOLDING A/S ANNOUNCEMENT NO. 04.2023 05.07.2023 TRESU Investment Holding A/S – adjustment to full year 2023 guidance TRESU Investment Holding A/S today announces an adjustment to full year guidance for 2023 mainly driven by continued long lead times on electrical components which has caused further delays in customer deliveries and projects execution. The delays have also caused extra costs for two projects to minimize the impacts of the delays for the customers. As a result, we are adjusting our expectations for full-year 2023 organic growth to 15-25% (previously: 30-40%) and given lower sales and additional resources to force progress on projects we expect our adjusted EBITDA margin to approximately 6-8% (previously: 7-12%). We are expecting cash flow generation from ordinary operating activities to be negative (previously:...

Continue reading

Cipher Mining Announces June 2023 Operational Update

Cipher Mining June 2023 Operating Report Satellite Image of the Odessa Data CenterCipher Mining June 2023 Operating Report Final Shipment of Canaan RigsNEW YORK, July 05, 2023 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited production and operations update for June 2023. Key HighlightsKey Metrics June 2023*BTC Mined 360Power Sales Equivalent BTC1 41BTC Sold 350BTC Held 417Deployed Mining Rigs 65,000Month End Operating Hash Rate (EH/s) 6.7*Approximate values Management Commentary In June, Cipher continued to expand operations at its Odessa facility and finished June with the potential to mine up to 17.1 bitcoin2 per day. “The month of June featured challenging operating conditions. Texas experienced record high temperatures, weak wind production...

Continue reading

Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimer’s Disease

CHART 1 Decline in Cognition Scores, FASCHART 2 Decline in Cognition Scores, patients with mild Alzheimer’sFigure 1 Historical declines on ADAS-Cog over 18 months in Alzheimer’s disease (MMSE 20-30), placebo arms vs simufilam treatment.Simufilam Slowed Cognitive Decline by 38% Versus Placebo Over 6 months in Patients with Mild-to-Moderate Alzheimer’s Disease. Drug Effects Favored Mild Alzheimer’s Disease. In Mild Alzheimer’s, Simufilam Improved Cognition Scores Over 6 Months. In Mild Alzheimer’s, Simufilam Stabilized Cognition Scores Over 18 Months. Oral Simufilam Continues to be Safe, Well Tolerated.AUSTIN, Texas, July 05, 2023 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company, today announced top-line clinical results from its Cognition Maintenance Study (CMS). The CMS...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.